Winter 03

Table of Contents

Message from the Dean

Featured Articles:

News & Notes

Alumni News

In Memoriam

Viewpoint

Calendar

Home


Of Mice, Men and Microscopy

Two years into the process, the Indiana Genomics Initiative has helped Indiana University and its School of Medicine substantially strengthen their research potential by attracting new scientists, funding new programs and acquiring the technology needed to advance the initiative.

By September 2002, more than $25 million in new research grants had been received with the assistance of INGEN programs and dollars, and millions more were awaiting review by such agencies as the National Institutes of Health. Following is an update on INGEN’s six programs and nine supporting research cores.

Bioethics
INGEN’s bioethics program is part of the new IU Center for Bioethics, which has conducted regular seminars for scientists, students and the public, and frequently briefs reporters from news media across the country. The center’s initiatives include the new position of director of the Fairbanks Center for Medical Ethics, an office created jointly with Clarian Health Partners; a new endowed chair in pediatric bioethics; and a new fellowship in pharmacogenomics ethics and public policy.

Bioinformatics
The bioinformatics program merges the power of computer technology with the techniques of molecular biology and genome analysis. IUSM officials are close to announcing a director of bioinformatics, after successfully competing with other institutions and businesses who are seeking the talents of the relatively few specialists in this new field. Meanwhile, INGEN leaders are developing strategies to integrate the many databases that are being created across IU by life sciences researchers.

Education
INGEN’s Scholars Program has enabled the recruitment of outstanding combined degree (MD, PhD) program students and has funded two years of summer research stipends for undergraduate students.

Genomics
Under the leadership of director Kenneth Cornetta, MD, newly appointed chair of the Department of Medical and Molecular Genetics, the resources of the INGEN Genomics Program are helping attract candidates for several new faculty research positions that will build on the department’s decades of research and clinical services.

Medical Informatics

The Medical Informatics Program builds on the resources of the Regenstrief Institute and IU-based Regenstrief Medical Records System, one of the world’s largest and oldest clinical medical databases. Expansion of this system to include information from all Indianapolis hospitals is under way. IU researchers also received a $1.04 million grant to develop a new Indiana Program of Excellence in Biomedical Computing.

Training
The growing needs of Indiana’s biomedical and healthcare industry are a challenge INGEN has met with the establishment of the Biotechnology Training Program. This two-year graduate program advances the training of lab specialists and researchers and prepares them for he ever-evolving field of biotechnology. The program’s first students enrolled in the fall of 2002. In January 2003, the program moves into its new home at the Biomedical Research and Training Center in downtown Indianapolis.

Animal Models
Several animal cores support INGEN research. The rodent phenotyping core is supporting collaborative work by IU and Stanford University scientists studying the effects of long-term alcohol consumption using the core’s genetically selected rats. The reproductive biology/animal stem cell core is developing models using zebra fish. The transgenic and knockout mouse and the Drosophila cores support researchers using mice and fruit flies, respectively.

Cell and Protein Expression
Housed in the Biochemistry Biotechnology Facility, this core has begun conducting large-scale protein expression and purification projects for IU scientists whose research involves protein interactions and other protein studies.

Genotyping and Gene Expression
IU scientists now can use this core to access the latest microarray techniques, which measure the activity of thousands of genes simultaneously. The core also enables researchers to detect minute genetic variations called SNPs (single nucleotide polymorphisms) that are important in disease and how people respond to drugs.

Human Expression
Faculty involved with this core are developing an informed consent system for volunteer participants in research studies. This will be crucial for proper archiving and use of human biological materials for future genetic research.

Microscopy Imaging
Housed in the Indiana Center for Biological Microscopy, the INGEN microscopy core provides state-of-the-art imaging capabilities to IU researchers. With support from INGEN, a $5 million grant from the National Institutes of Health brought a George M. O’Brien Kidney Research Center facility here that will be a national resource for renal imaging as well as a resource for IUSM faculty.

In Vivo Imaging
This core provides expertise and resources of the IU-based Indiana Center of Excellence in Biomedical Imaging. New imaging systems are enabling researchers to study behavioral, physical, and chemical characteristics of higher level organisms, from mice to humans.

Information Technology

Computing specialists in this core are helping IU scientists bring the power of the university’s supercomputer systems to biomedical research. For example, the core optimized software used by the Department of Medical Genetics to study the genetic components of diseases, cutting the time required to complete an analysis by seventy percent.

Proteomics
Just as genomics involves the study of the universe of genes, proteomics is the study of the universe of proteins made by those genes. Proteomics core operations at the School of Medicine and in the Department of Chemistry in Bloomington have already worked on at least three dozen research projects with university scientists.

Technology Transfer
The Indiana University Advanced Research and Technology Institute identifies research discoveries that may be developed into commercial products and protects such discoveries through the patenting process. ARTI has begun development of a life sciences
business incubator in the Indianapolis biotechnology research park.